Supplementary Table S8 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Read full text Summarise with VIRAT
Authors: Evelyn De Tavernier, Peter S. Kim, Eduardo M. Bruch, Virna F. Cortez-Retamozo, Lien Timmerman, Alyssa L. Flynn, Wouter Van Overbeke, Fabrice Tirode, Valeria Cintra Barbosa-Lorenzi, Peter A. Piepenhagen, Thuvan Dinh-Le, Ernesto Luna
+5 more Aiqun Li, Ann Baker, Alexey Rak, Lily I. Pao, Ana Paula B. Vintém
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Supplementary Table S8 shows ΔT/ΔC values on day 36

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research Cancer Immunotherapy and Biomarkers

Publication details

Publication date
2 April 2026
Language
EN